CELEX: 32008B0522
Language: en
Date: 2008-04-24 00:00:00
Title: 2008/522/EC: Decision of the European Parliament of 24 April 2007 on closing the accounts of the European Medicines Agency for the financial year 2005

15.7.2008   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               L 187/133
            
         
      DECISION OF THE EUROPEAN PARLIAMENT
   
   of 24 April 2007
   on closing the accounts of the European Medicines Agency for the financial year 2005
   (2008/522/EC)
   THE EUROPEAN PARLIAMENT,
   having regard to the final annual accounts of the European Medicines Agency for the financial year 2005 (1),
   having regard to the Court of Auditors' report on the final annual accounts of the European Medicines Agency for the financial year 2005, together with the Agency's replies (2),
   having regard to the Council's Recommendation of 27 February 2007 (5711/2007 — C6-0080/2007),
   having regard to the EC Treaty, and in particular Article 276 thereof,
   having regard to Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Communities (3), and in particular Article 185 thereof,
   having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (4), and in particular Article 68 thereof,
   having regard to Commission Regulation (EC, Euratom) No 2343/2002 of 19 November 2002 on the framework Financial Regulation for the bodies referred to in Article 185 of Council Regulation (EC, Euratom) No 1605/2002 (5), and in particular Article 94 thereof,
   having regard to Rule 71 of and Annex V to its Rules of Procedure,
   having regard to the Report of the Committee on Budgetary Control and the opinion of the Committee on the Environment, Public Health and Food Safety (A6-0099/2007),
   
               1.
            
            
               Notes that the final annual accounts of the European Medicines Agency for the financial years 2004 and 2005 are as follows:
               Revenue and expenditure account for the financial years 2004 and 2005
               
                           (in EUR 1000)
                        
                     
                            
                        
                        
                           2005
                        
                        
                           2004
                        
                     
                           
                              Revenue
                           
                        
                        
                            
                        
                        
                            
                        
                     
                           Fees relating to marketing authorisations
                        
                        
                           72 613
                        
                        
                           68 412
                        
                     
                           Commission subsidy including contributions received from the EE
                        
                        
                           22 847
                        
                        
                           20 529
                        
                     
                           Community subsidy for orphan medicines
                        
                        
                           6 110
                        
                        
                           4 026
                        
                     
                           Contributions for Community programmes
                        
                        
                           0
                        
                        
                           0
                        
                     
                           Administrative revenue
                        
                        
                           3 423
                        
                        
                           1 973
                        
                     
                           Sundry revenue
                        
                        
                           1 643
                        
                        
                           1 473
                        
                     
                           
                              Total revenue (a)
                           
                        
                        
                           
                              106 636
                           
                        
                        
                           
                              96 413
                           
                        
                     
                           
                              Expenditure
                           
                        
                        
                            
                        
                        
                            
                        
                     
                           Staff expenditure
                        
                        
                           40 057
                        
                        
                           34 333
                        
                     
                           Administrative expenditure
                        
                        
                           17 022
                        
                        
                           11 224
                        
                     
                           Operating expenditure
                        
                        
                           41 999
                        
                        
                           38 573
                        
                     
                           Depreciation
                        
                        
                           5 333
                        
                        
                           3 650
                        
                     
                           Other expenses
                        
                        
                           104
                        
                        
                           280
                        
                     
                           
                              Total expenditure (b)
                           
                        
                        
                           
                              104 515
                           
                        
                        
                           
                              88 060
                           
                        
                     
                           
                              Operating result (c = a - b)
                           
                        
                        
                           
                              2 121
                           
                        
                        
                           
                              8 353
                           
                        
                     
                           
                              Financial result (e)
                           
                        
                        
                           2 257
                        
                        
                           1 160
                        
                     
                           
                              Economic outturn (f = c + e)
                           
                        
                        
                           
                              4 378
                           
                        
                        
                           
                              9 513
                           
                        
                     
                           
                              Source: The Agency's data — This table summarises the data provided by the Agency in its annual accounts;
                        
                     
         
               2.
            
            
               Approves closing the accounts of the European Medicines Agency for the financial year 2005;
            
         
               3.
            
            
               Instructs its President to forward this Decision to the executive director of the European Medicines Agency, the Council, the Commission and the Court of Auditors, and to arrange for its publication in the Official Journal of the European Union (L series).
            
         
      
         
            The President
         
         Hans-Gert PÖTTERING
         
      
      
         
            The Secretary-General
         
         Harald RØMER
         
      
   
   
      (1)  OJ C 266, 31.10.2006, p. 4.
   
      (2)  OJ C 312, 19.12.2006, p. 12.
   
      (3)  OJ L 248, 16.9.2002, p. 1. Regulation as amended by Regulation (EC, Euratom) No 1995/2006 (OJ L 390, 30.12.2006, p. 1).
   
      (4)  OJ L 136, 30.4.2004, p. 1. Regulation as amended by Regulation (EC) No 1901/2006 (OJ L 378, 27.12.2006, p. 1).
   
      (5)  OJ L 357, 31.12.2002, p. 72.